Assessing heart disease and diabetes risk in women during and after pregnancy
Official title: Preconception to pOst-partum Study of Cardiometabolic Health in Primigravid PregnancY
Run by Cambridge University Hospitals NHS Foundation Trust · NCT05856318 · Data updated 2026-11-12
This study is trying to see how pregnancy complications like pre-eclampsia affect women's chances of developing heart disease and diabetes later on, by following women who are trying to get pregnant and comparing them to those who aren't.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 45 Years |
| Sex | Women only |
| Enrollment | 3500 (estimated) |
| Sponsor | Cambridge University Hospitals NHS Foundation Trust Academic / other |
| Locations | 7 sites (Cambridge and 6 other locations) |
| Status | Recruiting |
| Started | May 24, 2023 |
| Main results expected | December 2027 |
| Study ends | December 2052 |
| Registry record updated | April 9, 2024 |
| Trial ID | NCT05856318 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are nulliparous women aged 18 to 45 who are actively considering pregnancy within the next year.
✕Probably not a fit
Patients currently pregnant, those with established infertility, or individuals with certain chronic conditions will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study focuses on women who experience placental complications during pregnancy, such as pre-eclampsia and gestational hypertension, to evaluate their risk factors for developing heart disease and diabetes. The study will recruit women actively trying to conceive and follow them through their pregnancy and up to 12 months postpartum. Additionally, a control group of women not planning pregnancy will be included to compare outcomes. The goal is to understand how placental syndromes impact long-term cardiovascular health and to identify potential preventive measures.
Why it matters
Potential benefit: If successful, this study could lead to improved strategies for reducing the risk of heart disease and diabetes in women who experience placental syndromes.
How similar studies have gone: Other studies have indicated significant associations between placental syndromes and long-term cardiovascular risks, suggesting this approach is grounded in existing evidence.
Who can join: the full rules
Show full inclusion / exclusion criteria
Pregnancy Arm Inclusion Criteria: To be included in the trial the participant must: * Nulliparous (no previous pregnancy beyond 20 weeks' gestation) * Actively considering pregnancy within approximately 12 months * Aged between 18 and 45 years * Ability to consent and willing to participate Pregnancy Arm Exclusion Criteria: The presence of any of the following will preclude participant inclusion: * Currently pregnant * Established infertility * Planning or actively using fertility treatments (e.g. IVF, ICSI, FET, IUI) * Assigned male sex at birth * Autoimmune disease (e.g. rheumatoid arthritis, lupus) * Thrombophilia * Type 1 diabetes * Known advanced chronic kidney disease (stages 4-5) * Malignant hypertension * Clinically manifest CVD (e.g. previous myocardial infarction, stroke) * Active cancer/being treated for cancer currently (other than skin cancer) * Any other condition preventing full participation in the study Non-Pregnancy Arm Inclusion criteria To be included in the trial the participant must: * Nulliparous (no previous pregnancy beyond 20 weeks' gestation) * Not planning to conceive during next 18 months * Aged between 18 and 45 years * Ability to consent and willing to participate Non-Pregnancy Exclusion Criteria The presence of any of the following will preclude participant inclusion: * Currently pregnant * Planning or actively using fertility treatments (e.g. IVF, ICSI, FET, IUI) * Assigned male sex at birth * Autoimmune disease (e.g. rheumatoid arthritis, lupus) * Thrombophilia * Type 1 diabetes * Known advanced chronic kidney disease (stages 4-5) * Malignant hypertension * Clinically manifest CVD (e.g. previous myocardial infarction, stroke) * Active cancer/being treated for cancer currently (other than skin cancer) * Any other condition preventing full participation in the study
Where it's running
-
Cambridge University Hospitals NHS Foundation Trust
Cambridge, United Kingdom Recruiting -
NHS Greater Glasgow and Clyde
Glasgow, United Kingdom Recruiting -
Imperial College Healthcare NHS Trust
London, United Kingdom Recruiting -
University College London Hospitals NHS Foundation Trust
London, United Kingdom Not yet recruiting -
King's College Hospital NHS Foundation Trust
London, United Kingdom Not yet recruiting -
St George's University Hospitals NHS Foundation Trust
London, United Kingdom Not yet recruiting
Show 1 more location
-
Manchester University NHS Foundation Trust
Manchester, United Kingdom Not yet recruiting
Study contacts
- Principal investigator: Ian Wilkinson, MD — Cambridge University Hospitals NHS Foundation Trust
- Study coordinator: Heike Templin
- Email: cuh.poppycctu@nhs.net
- Phone: 0044 1223 250874
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Assessing pancreas changes during pregnancy
This study is testing how the size of the pancreas changes during pregnancy in women and their babies, especially looking at the effects of diabetes.
-
Personalized dietary responses for better health
This study is testing how different foods affect people's health based on their unique responses, and it's for individuals taking part in the ZOE testing program.
-
Collection and storage of human biological samples for research
This study is about collecting and storing biological samples from people with different health conditions to help researchers find better ways to prevent, diagnose, and treat diseases.
-
Postpartum exercise to improve heart and metabolic health in women at high risk for preeclampsia
This pilot study tests whether a 12‑week postpartum exercise program can improve heart health and metabolic markers in women who were at high risk for preeclampsia.
-
New virtual care pathway for older adults with chronic diseases
A teleconsultation-based care pathway for adults 60+ with hypertension, diabetes, or dyslipidemia to see if it’s feasible and cost-saving in Malaysian primary care compared with usual clinic visits.
-
Benefits of Retained Insulin for Good Health in Diabetes
This study tests whether preserving or restoring a person’s own insulin production can improve quality of life and blood sugar control for people who need insulin to manage diabetes.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.